Begin main content

Call for Patient Input: Izba

January 31, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Izba Brand name Generic name Manufacturer Indi...

Call for Patient Input: Baricitinib

January 30, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Baricitinib Brand name Generic name Manufactur...

Call for Patient Input: Repatha

January 20, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Repatha Brand name Generic name Manufacturer I...

New at CADTH — January 2017

January 17, 2017
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

CADTH Recognition Awards — Nominations Now Being Accepted

January 11, 2017
We are pleased to announce that nominations are now being accepted for two prestigious awards for outstanding achievement in the field of health technology assessment (HTA) in Canada. The Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment recognizes individuals whose outstanding achievements have significantly advanced the f...